ATE523191T1 - Antimykotischer schaum mit ciclopiroxolamin und zinkpyrithion sowie medizinische und kosmetische anwendung dafür - Google Patents

Antimykotischer schaum mit ciclopiroxolamin und zinkpyrithion sowie medizinische und kosmetische anwendung dafür

Info

Publication number
ATE523191T1
ATE523191T1 AT08749588T AT08749588T ATE523191T1 AT E523191 T1 ATE523191 T1 AT E523191T1 AT 08749588 T AT08749588 T AT 08749588T AT 08749588 T AT08749588 T AT 08749588T AT E523191 T1 ATE523191 T1 AT E523191T1
Authority
AT
Austria
Prior art keywords
ciclopiroxolamine
medical
cosmetic use
zinc pyrithion
antifungal
Prior art date
Application number
AT08749588T
Other languages
English (en)
Inventor
Michel Jeanjean
Nadine Senegas
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of ATE523191T1 publication Critical patent/ATE523191T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08749588T 2007-04-18 2008-04-17 Antimykotischer schaum mit ciclopiroxolamin und zinkpyrithion sowie medizinische und kosmetische anwendung dafür ATE523191T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0754558A FR2915097B1 (fr) 2007-04-18 2007-04-18 Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
PCT/EP2008/054657 WO2008135361A2 (fr) 2007-04-18 2008-04-17 Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques

Publications (1)

Publication Number Publication Date
ATE523191T1 true ATE523191T1 (de) 2011-09-15

Family

ID=38774119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08749588T ATE523191T1 (de) 2007-04-18 2008-04-17 Antimykotischer schaum mit ciclopiroxolamin und zinkpyrithion sowie medizinische und kosmetische anwendung dafür

Country Status (9)

Country Link
US (1) US8372440B2 (de)
EP (1) EP2142171B1 (de)
JP (1) JP2010524888A (de)
AR (1) AR066117A1 (de)
AT (1) ATE523191T1 (de)
CA (1) CA2684126A1 (de)
ES (1) ES2369314T3 (de)
FR (1) FR2915097B1 (de)
WO (1) WO2008135361A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110201588A1 (en) * 2010-02-16 2011-08-18 James Robert Schwartz Post Foaming Gel Composition Comprising An Anti-Irritation Agent
MX350993B (es) * 2010-10-28 2017-09-27 Procter & Gamble Composiciones para el cuidado personal que comprenden una piritiona y un quelante de hierro.
CN113905715B (zh) 2019-06-28 2025-04-15 宝洁公司 光增强处理方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033895A (en) * 1975-12-24 1977-07-05 Revlon, Inc. Non-irritating shampoo compositions containing stearyl amine oxide
JPH0635373B2 (ja) * 1991-10-19 1994-05-11 協和産業株式会社 泡沫状エアゾール剤
US5654293A (en) * 1993-01-21 1997-08-05 Janssen Pharmaceutica N.V. Topical oil-in-water emulsion compositions containing ketoconazole and an acetonide glucocorticosteroid
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
JPH08175982A (ja) * 1994-12-21 1996-07-09 Lederle Japan Ltd ４−ビフェニリル酢酸組成液
US6211139B1 (en) * 1996-04-26 2001-04-03 Goldschmidt Chemical Corporation Polyester polyquaternary compounds, compositions containing them, and use thereof
US5798093A (en) * 1997-03-14 1998-08-25 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
DE102004004394A1 (de) * 2004-01-29 2005-08-11 Wella Ag Mikroemulsion
US20050238597A1 (en) * 2004-04-26 2005-10-27 Mccook John P Topical treatment of acne, seborrheic dermatitis, and oily skin with formulations containing histamine antagonists
US20050255048A1 (en) * 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
WO2008076416A1 (en) 2006-12-15 2008-06-26 The Procter & Gamble Company Skin care composition

Also Published As

Publication number Publication date
EP2142171A2 (de) 2010-01-13
WO2008135361A2 (fr) 2008-11-13
ES2369314T3 (es) 2011-11-29
AR066117A1 (es) 2009-07-22
US20100129468A1 (en) 2010-05-27
CA2684126A1 (fr) 2008-11-13
FR2915097B1 (fr) 2012-09-28
FR2915097A1 (fr) 2008-10-24
WO2008135361A3 (fr) 2009-02-26
US8372440B2 (en) 2013-02-12
EP2142171B1 (de) 2011-09-07
JP2010524888A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
EP2147954A4 (de) Photolumineszenzpigment und davon gebrauch machende kosmetische zubereitung
DE112008002791A5 (de) Verbesserte arzneimittelbeschichtete Medizinprodukte, deren Herstellung und Verwendung
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
EP2186528A4 (de) Arzneimittel mit hif-1-alpha- and hif-2-alpha-expressionshemmer
HRP20190031T1 (hr) Sintetski triterpenoidi i postupci njihove upotrebe u liječenju bolesti
IL213168A0 (en) 1,2,4-oxadiazole derivatives and their therapeutic use
IL234064B (en) A therapeutic combination comprising trastuzumab-mcc-dm1 and docetaxel for use in the treatment of a cancer expressing erbb2
BRPI0923747A2 (pt) "tratamento de safras transgênicas com misturas de fiprolas e cloroniconilas".
IL212856A (en) Human antibodies against human tissue factor, conjugates and uses thereof
GB0719803D0 (en) Therapeutic compounds and their use
DE602008001981D1 (de) Stellung und therapeutische verwendung
EP1758597A4 (de) Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz
GB0719644D0 (en) Therapeutic compounds and their use
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
IL186557A0 (en) Syringe with valve opened upon verification of correct patient identity
GB0724251D0 (en) Therapeutic compounds and their use
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
GB0722680D0 (en) Therapeutic compounds and their use
FR2928149B1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
EP2341047A4 (de) Cyclohexanderivat und pharmazeutische anwendung davon
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE540023T1 (de) Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
DE602005023325D1 (de) Harzzusammensetzung und formkörper daraus
AT508430A5 (de) Formbauteil und dessen verwendung
ATE459608T1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties